Literature DB >> 4388633

Effect of steroid hormone on activation of Endoxan (cyclophosphamide).

T Hayakawa, N Kanai, R Yamada, R Kuroda, H Higashi, H Mogami, D Jinnai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4388633     DOI： 10.1016/0006-2952(69)90017-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  11 in total

Review 1.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 2.  Protection by catatoxic steroids against cyclophosphamide-induced organ lesions.

Authors:  H Selye
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

Review 3.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: a review.

Authors:  J G Gambertoglio; W J Amend; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

Review 4.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 5.  Clinical management of cytotoxic drug overdose.

Authors:  L L Thomas; M J Mertens; A E von dem Borne; C J van Boxtel; C H Veenhof; E P Veies
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

6.  Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid.

Authors:  G R Sarma; S Kailasam; N G Nair; A S Narayana; S P Tripathy
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

Review 7.  Pharmacokinetic drug interactions with anticancer drugs.

Authors:  P M Loadman; M C Bibby
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

8.  Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL/MpJ-lpr/lpr mice.

Authors:  W N McKenzie; E V Sunderrajan; J L Kavanaugh; S Braun; L Ansbacher; S E Walker
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

9.  The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice.

Authors:  C E Sheard; J A Double; M C Berenbaum
Journal:  Br J Cancer       Date:  1971-12       Impact factor: 7.640

10.  Evaluation of cyclophosphamide dosage schedules in breast cancer.

Authors:  B A Stoll
Journal:  Br J Cancer       Date:  1970-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.